Skip to main content
. Author manuscript; available in PMC: 2020 May 4.
Published in final edited form as: Cell Tissue Res. 2014 Jul 4;358(1):203–216. doi: 10.1007/s00441-014-1937-2

Fig. 9.

Fig. 9

Effects of transforming growth factor-β1 (TGF-β1) and Notch inhibition by γ-secretase inhibitor (DAPT) on Sox10 and SM-MHC levels in a representative vSMC line, namely mSMCs. The expression of Sox10 and SM-MHC was determined by immunocytochemistry. Cells were grown in media containing 10 % FBS supplemented with (a–j TGF-β1 (1 ng/ml) or (k–t) 10 xM DAPT for 3 days. Scale bars are 25 μm. Ratio of Sox10:SM-MHC (sm-2)-positive cells in untreated and in (u) TGF-β1-treated and (v) DAPT-treated cells. Data are representative of three independent wells